Browse > Article
http://dx.doi.org/10.3346/jkms.2018.33.e286

Sorafenib for Recurrent Hepatocellular Carcinoma after Liver Transplantation  

Kim, Bo Hyun (Center for Liver Cancer, National Cancer Center)
Park, Joong-Won (Center for Liver Cancer, National Cancer Center)
Publication Information
Journal of Korean Medical Science / v.33, no.45, 2018 , pp. 286.1-286.3 More about this Journal
Keywords
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996;334(11):693-9.   DOI
2 Lee HW, Suh KS. Liver transplantation for advanced hepatocellular carcinoma. Clin Mol Hepatol 2016;22(3):309-18.   DOI
3 Kang SH, Cho H, Cho EJ, Lee JH, Yu SJ, Kim YJ, et al. Efficacy of sorafenib for the treatment of post-transplant hepatocellular carcinoma recurrence. J Korean Med Sci 2018;33(45):e283.   DOI
4 Agopian VG, Harlander-Locke M, Zarrinpar A, Kaldas FM, Farmer DG, Yersiz H, et al. A novel prognostic nomogram accurately predicts hepatocellular carcinoma recurrence after liver transplantation: analysis of 865 consecutive liver transplant recipients. J Am Coll Surg 2015;220(4):416-27.   DOI
5 Toso C, Cader S, Mentha-Dugerdil A, Meeberg G, Majno P, Morard I, et al. Factors predicting survival after post-transplant hepatocellular carcinoma recurrence. J Hepatobiliary Pancreat Sci 2013;20(3):342-7.   DOI
6 Mehta N, Heimbach J, Harnois DM, Sapisochin G, Dodge JL, Lee D, et al. Validation of a Risk Estimation of Tumor Recurrence After Transplant (RETREAT) score for hepatocellular carcinoma recurrence after liver transplant. JAMA Oncol 2017;3(4):493-500.   DOI
7 Yoo JJ, Chung GE, Lee JH, Nam JY, Chang Y, Lee JM, et al. Sub-classification of advanced-stage hepatocellular carcinoma: a cohort study including 612 patients treated with sorafenib. Cancer Res Treat 2018;50(2):366-73.   DOI
8 Cho JY, Paik YH, Lim HY, Kim YG, Lim HK, Min YW, et al. Clinical parameters predictive of outcomes in sorafenib-treated patients with advanced hepatocellular carcinoma. Liver Int 2013;33(6):950-7.   DOI